AC Immune SA (ACIU)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 2.3500 |
| Open | 2.3200 |
| Bid | 2.2900 x 100 |
| Ask | 2.3900 x 100 |
| Day's range | 2.3200 - 2.3791 |
| 52-week range | 1.9000 - 5.1400 |
| Volume | |
| Avg. volume | 183,245 |
| Market cap | 232.412M |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- Simply Wall St.
Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%
AC Immune SA ( NASDAQ:ACIU ) shareholders should be happy to see the share price up 17% in the last month. But over the...
- Zacks
AbbVie (ABBV) Announces Appointment of New CEO Robert Michael
Robert Michael is set to succeed Richard A. Gonzalez as AbbVie's (ABBV) CEO, effective Jul 1, 2024.
© 2024 Yahoo. All rights reserved.